ABSTRACT
The study assessed changes in cerebral blood flow and need for chronic blood transfusions in sickle cell disease children after splenectomy. A retrospective chart review of 40 children splenectomized between 1999 and 2014 was performed. The mean time-average maximum velocity before splenectomy was 129 cm/sec; which increased to 157 cm/sec and then decreased to 137 cm/sec, 2 and 5 years postsplenectomy, respectively. There was a persistent and statistically significant elevation in platelet count noted after splenectomy. The mean cerebral blood flow velocity seemed to increase transiently after splenectomy. Close monitoring and screening for stroke risk should be continued postsplenectomy.
Subject(s)
Anemia, Sickle Cell/physiopathology , Anemia, Sickle Cell/surgery , Cerebrovascular Circulation , Splenectomy , Adolescent , Blood Flow Velocity , Child , Child, Preschool , Female , Follow-Up Studies , Humans , MaleABSTRACT
We performed a retrospective chart review of children with sickle cell disease hospitalized for fever at our local institution. We reviewed 456 hospitalizations in 133 patients between January 2006 and June 2012. The prevalence of true bacteremia was 4%. The mean C-reactive protein values and temperatures were nonsignificantly higher in patients with positive blood cultures. The mean time to detection was 22.5 hours in bacteremia compared to 32.6 hours in blood cultures that grew contaminants (p = .034). Only two (0.4%) cases of pneumococcal bacteremia were reported and both occurred before May 2010, which marks the introduction of 13-valent pneumococcal vaccine (PCV13). Both patients with pneumococcal bacteremia had discontinued penicillin prophylaxis after the age of 5 years. The first patient was immunized but contracted a nonvaccine serotype (23B). The second patient was partially vaccinated and acquired a vaccine-preventable serotype (23F). Both serotypes were sensitive to ceftriaxone and vancomycin; one was resistant to penicillin. This is the first study reporting the prevalence of pneumococcal bacteremia since the introduction of PCV13.
Subject(s)
Anemia, Sickle Cell/complications , Pneumonia, Pneumococcal/epidemiology , Streptococcus pneumoniae/isolation & purification , Adolescent , Alabama/epidemiology , Anemia, Sickle Cell/microbiology , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Male , Pneumococcal Vaccines/therapeutic use , Pneumonia, Pneumococcal/microbiology , Pneumonia, Pneumococcal/prevention & control , Prevalence , Prognosis , Retrospective StudiesABSTRACT
Mucormycosis is a rare, but invasive infection caused by ubiquitous molds. Amphotericin B and surgery have been known to help improve the outcome. Sporadic case reports support the use of posaconazole in adults. We report a toddler with acute lymphoblastic leukemia who acquired rhino-orbital mucormycosis caused by Rhizopus species at the end of induction chemotherapy. She was successfully treated with multiple surgical debridements, amphotericin B, posaconazole and hyperbaric oxygen therapy. In conclusion, mucormycosis is a serious infection that requires aggressive surgical and medical therapy. To the best of our knowledge the use of posaconazole combined with hyperbaric oxygen therapy has not been reported in a toddler with leukemia and invasive Rhizopus sp. infection. This approach was found to be safe and effective in our patient.
Subject(s)
Hyperbaric Oxygenation , Mucormycosis/microbiology , Orbital Diseases/microbiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Rhizopus/drug effects , Triazoles/therapeutic use , Adult , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Child, Preschool , Combined Modality Therapy , Female , Humans , Mucormycosis/diagnosis , Mucormycosis/drug therapy , Orbital Diseases/drug therapy , Orbital Diseases/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/microbiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy , Prognosis , Remission Induction , Tomography, X-Ray ComputedABSTRACT
We report a rare case of juvenile cobalamin deficiency who presented at the age of 17 years. He was underweight and had skin changes, normocytic anemia, and autonomic dysfunction, which led to adynamic ileus and acute postrenal failure. The expected macrocytosis was masked by an underlying alpha-thalassemia trait. The patient had an excellent response to parenteral cobalamin treatment.
Subject(s)
Autonomic Nervous System Diseases/etiology , Exanthema/etiology , Vitamin B 12 Deficiency/complications , Vitamin B 12/blood , Adolescent , Cryptorchidism/complications , Gastroschisis/complications , Humans , Hydronephrosis/complications , Hydronephrosis/congenital , Male , Multicystic Dysplastic Kidney/complications , Ureteral Obstruction/complications , Ureteral Obstruction/congenital , Vitamin B 12 Deficiency/physiopathologyABSTRACT
We review a unique case of NUT midline carcinoma that presented in a young girl with an initial diagnosis of tonsillar abscess. We stress the importance of assaying poorly differentiated carcinomas in young patients for the t(15;19) translocation. Our patient presented with tonsillar enlargement and cervical lymphadenopathy mimicking acute tonsillitis. The clinical suspicion for malignancy arose after an aspirate from the tonsil did not yield any pus, and biopsy of a cervical lymph node demonstrated undifferentiated carcinoma. Further analysis by fluorescence in situ hybridization was positive for rearrangements in both BRD4 and NUT genes consistent with NUT carcinoma. In addition, fluorodeoxyglucose-positron emission tomography (FDG-PET) revealed a very high standard uptake value in both the primary tumor and metastatic foci, suggesting that FDG-PET could be a useful tool in the staging and follow-up of NUT midline carcinoma.
